Login/Sign Up

MRP ₹341107
(Inclusive of all Taxes)
₹51166.1 Cashback (15%)
Gazyva 1000 mg Injection is used to treat Chronic Lymphocytic Leukaemia and Follicular Lymphoma. Gazyva 1000 mg Injection contains Obinutuzumab. It works by inhibiting the B-cell lymphocytes responsible for the multiplication of cancer cells, thereby preventing the growth and further spread of cancerous or non-cancerous cells. This medicine is known to cause fetal B-cell depletion in neonates. Hence, inform your physician if you are pregnant.
Provide Delivery Location
About Gazyva 1000 mg Injection
Gazyva 1000 mg Injection is an anti-cancer medicine used in the treatment of chronic lymphocytic leukaemia (CLL). Chronic lymphocytic leukaemia is a cancer that occurs in the bone marrow and blood. Gazyva 1000 mg Injection is used in combination with chlorambucil for the treatment of CLL, in combination with bendamustine for the treatment of follicular lymphoma in patients who relapsed after or are refractory to a rituximab-containing regimen and in patients with previously untreated stage II bulky, III or IV follicular lymphoma.
Gazyva 1000 mg Injection contains Obinutuzumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.
Gazyva 1000 mg Injection may cause certain side effects, such as nausea, vomiting, diarrhoea, constipation, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Gazyva 1000 mg Injection. Hence, do not self-administer.
While taking Gazyva 1000 mg Injection if you experience any allergic reaction, inform your doctor. Before taking the Gazyva 1000 mg Injection, let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Gazyva 1000 mg Injection is known to cause fetal B-cell depletion in neonates. Hence, inform your physician if you are pregnant.
Uses of Gazyva 1000 mg Injection
Gazyva 1000 mg Injection is used in the treatment of Chronic Lymphocytic Leukaemia, and Follicular Lymphoma. The detailed uses of Gazyva 1000 mg Injection are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Gazyva 1000 mg Injection contains Obinutuzumab, which belongs to the class of CD20-directed cytolytic antibodies. It is used in the treatment of chronic lymphocytic leukaemia and follicular lymphoma. This medicine works by binding to the CD20 antibody and causes lysis of B-cell lymphocytes responsible for the multiplication of cancer cells. This causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
How Gazyva 1000 mg Injection Works
Storage
What if I have taken an overdose of Gazyva 1000 mg Injection
Drug Warnings
Gazyva 1000 mg Injection should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Gazyva 1000 mg Injection may cause remission of active infections, severe skin reactions, reactivation of hepatitis B Virus, increased bilirubin levels, progressive multifocal leukoencephalopathy, tumour lysis syndrome (tumor cells release their contents into the bloodstream), and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Gazyva 1000 mg Injection may cause fetal B-cell depletion in infants. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Gazyva 1000 mg Injection is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
It is unknown whether Gazyva 1000 mg Injection interacts with alcohol. Consult your doctor.
Pregnancy
Unsafe
Gazyva 1000 mg Injection is not recommended for use in pregnancy as it may cause fatal B-lymphocyte depletion in your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Gazyva 1000 mg Injection.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Gazyva 1000 mg Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Caution
Gazyva 1000 mg Injection will be administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Gazyva 1000 mg Injection. Gazyva 1000 mg Injection may cause increased bilirubin levels and liver failure. Hence, inform your doctor if you observe any symptoms such as fatigue, yellow discolouration of eyes, and dark coloured urine. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Kidney
Caution
It is not known whether Gazyva 1000 mg Injection can be taken if you have kidney impairment. However, inform your doctor if you have a pre-existing or a history of kidney disease before receiving Gazyva 1000 mg Injection.
Children
Unsafe
Gazyva 1000 mg Injection is not recommended for use in children as the safety and efficacy are not established.
Heart
Please consult your doctor before receiving Gazyva 1000 mg Injection if you have pre-existing heart problems. Your doctor will prescribe Gazyva 1000 mg Injection if the benefits outweigh the risks.
Geriatrics
Safe if prescribed
Gazyva 1000 mg Injection is generally considered safe when used under medical supervision in geriatric patients; however, significant precautions should be taken due to age-related sensitivities.
Gazyva 1000 mg Injection is used to treat Chronic Lymphocytic Leukaemia, and Follicular Lymphoma.
Gazyva 1000 mg Injection contains Obinutuzumab, which works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.
Gazyva 1000 mg Injection may cause reactivation of serious infections, tumour lysis syndrome, and anaphylactic reactions in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
Halsted Pharma Pvt Ltd
Glenmark Pharmaceuticals Ltd
Neon Laboratories Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Axiommax Oncology Pvt Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Amps Biotech Biotech Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Allieva Pharma Pvt Ltd
Astra Zeneca Pharma India Ltd
Lucien Life Sciences
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Bruck Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley & Bdl
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd